期刊文献+

PDCD4增强鼻咽癌细胞系CNE1对顺铂化疗敏感性机制研究 被引量:1

PDCD4 enhances the sensitivity mechanism of nasopharyngeal carcinoma cell line CNE1 to cisplatin chemotherapy
下载PDF
导出
摘要 目的:探讨抑癌基因程序性细胞死亡因子4(the programmed cell death 4,PDCD4)在促进化疗药物顺铂(CDDP)诱导肿瘤细胞凋亡中的作用及可能的机制。方法:CCK8法检测人鼻咽癌系CNE1细胞转染PDCD4前后对CDDP导致的细胞毒性作用影响; Annexin V/FITC和PI凋亡检测转染PDCD4前后对CDDP诱导凋亡的作用; Western blot实验初步探讨其可能的分子机制。结果:PDCD4增强CDDP对人鼻咽癌系CNE1细胞的杀伤作用; PDCD4增加CDDP诱导人鼻咽癌系CNE1细胞凋亡率;机制研究发现PDCD4显著降低人鼻咽癌系CNE1细胞中Twist及MDR1蛋白的表达量,从而促进化疗敏感性。结论:PDCD4通过抑制Twist蛋白增强化疗药物敏感性,提示其参与了鼻咽癌化疗治疗进程。 AIM:To investigate the roles of PDCD4 involved in promoting cisplatin(CDDP)induced tumor cell apoptosis.METHODS:CCK8 method was used to detect the cytotoxicity induced by CDDP in human nasopharyngeal carcinoma cell line(CNE1)before and after PDCD4 transfection.The rate of apoptosis for CDDP-induced nasopharyngeal carcinoma cells was investigated using flow cytometry before and after transfection of PDCD4.Western blot method was used to probe the molecular mechanisms involved in the chemosensitivity.RESULTS:PDCD4 enhanced the killing effect of CDDP on human nasopharyngeal carcinoma cell line CNE1;PDCD4 increased CDDP-induced apoptotic rate of human nasopharyngeal carcinoma cell line CNE1;mechanism study found that PDCD4 significantly decreased the expression of Twist and MDR1 protein,thereby promoting the cell chemosensitivity.CONCLUSION:PDCD4 enhances the sensitivity of chemotherapy drugs by inhibiting Twist protein,suggesting that PDCD4 might serve as a chemotherapy target in nasopharyngeal carcinoma treatment.
作者 李琳 王文红 王洪梅 LI Lin;WANG Wenhong;WANG Hongmei(Department of Pharmacology,Heze Medical College,Heze 274000,Shandong,China;Otorhinolaryngological Department,Municipal Hospital of Heze,Heze 274000,Shandong,China;Central Hospital of Zibo Affiliated to Shandong University,Zibo 255036,Shandong,China)
出处 《中国临床药理学与治疗学》 CAS CSCD 2019年第1期9-13,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家自然科学基金青年科学基金项目(81602327)
关键词 鼻咽癌 PDCD4 TWIST 顺铂 nasopharyngeal carcinoma PDCD4 Twist cisplatin
  • 相关文献

参考文献2

二级参考文献19

  • 1许文嵘,姚堃,陈云,尹全章,徐建,周锋.EB病毒潜伏膜蛋白2A胞外区重组基因在大肠杆菌中的表达及其在血清学检测中的应用[J].南京医科大学学报(自然科学版),2007,27(3):209-212. 被引量:1
  • 2Chen R, Zhang D, Mao Y, et al. A human Fabbased immunoconjugate specific for the LMPI extraeellular domain inhibits nasopharyngeal carcinoma growth in vitro and in vivo[ J]. Mol Cancer Thor, 2012,11 (3) : 594-603.
  • 3Hsiao JR, Jin YT, Tsai ST. Detection of cell free Ep- stein-Barr virus DNA in sera from patients with naso- pharyngeal carcinoma[ J ]. Cancer, 2002,94( 3 ) :723- 729.
  • 4Konishi K, Maruo S, Kato H,et al. Role of Epstein-Barr virus-encoded latent memb -rane protein 2A on virus- induced immortalization and virus activation [ J ]. J Gen Virol,2001,82(6) : 1451- 1456.
  • 5Swanson-Mungerson M, lkeda M, Levl+, et al. Iden- tification of latent membrane protein 2A ( LMP2A ) spe- cific targets for treatment and eradication of Epstein- Barr viru -s (EBV)-associated diseases [ J ] . J Anti- microb Chemother, 2003, 52(2) : 152- 154.
  • 6lngham R J, Raaijmakers J, lim CS, et al. The Ep- stein-Barr virus protein, latent me -mbrane protein 2A, co-opts tyrosine kinases used by the T cell recep- tor [J] . J Biol Che,n, 2005, 280(40) : 34133- 34142.
  • 7Yong LS, Dawson CW, Eliopoulos AG. The expres- sion and function of Epstein- Barr virus encoded latent genes[J]. J Clin Pathol: Mol Pathol, 2000,53(5): 238-247.
  • 8Longnecker R. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein -Barr virus persistence [J] ? Adv Cancer Res, 2000,79:175-200.
  • 9曹清,唐小军,李文杰,熊四平,毛园,熊林,刘玉,王长军,冯振卿,陈仁杰.EBV编码潜伏膜蛋白2A抗原表位的串联表达及其免疫原性分析[J].南京医科大学学报(自然科学版),2013,33(5):593-597. 被引量:2
  • 10赵利容,罗泊涛,陈小毅.EB病毒编码的潜伏膜蛋白2A在鼻咽癌中的研究进展[J].山东医药,2013,53(28):102-104. 被引量:4

共引文献12

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部